Abiopharma

CYPHER METAVERSE INC. (META)

Symbol	META
Name	CYPHER METAVERSE INC.
Sector	TECHNOLOGY
Region	North America
Industry	-
Address	V6C 2G8 Canada BC 1780-355 Burrard Street
Telephone	+1 (778) 373-8578
Fax	—
Email	—
Website	https://www.cypher-meta.com/
Incorporation	CA
Incorporated On	2013
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC;NASDAQ
Auditor	Antares Professional Corporation;
Audit Status	AUDITED
Reporting Status	International Reporting: Canadian Securities Exchange
CIK	0001721400
Description	Cypher Metaverse Inc. (Cypher, CODE, or the Company) seeks early-stage investments in emerging technology sectors, including the blockchain ecosystem, fintech and the metaverse. The Company identifies such opportunities and applies its relationships and capital to advance its interests. Additional info from NASDAQ: Meta is the worlds largest online social network, with over 3.6 billion monthly active users. Users engage with each other in different ways, exchanging messages and sharing news events, photos, and videos. On the video side, the firm is in the process of building a library of premium content and monetizing it via ads or subscription revenue. Meta refers to this as Facebook Watch. The firms ecosystem consists mainly of the Facebook app, Instagram, Messenger, WhatsApp, and many features surrounding these products. Users can access Facebook on mobile devices and desktops. Advertising revenue represents more than 90% of the firms total revenue, with 50% coming from the U.S. and Canada and 25% from Europe. With gross margins above 80%, Meta operates at a 30%-plus margin. Additional info from OTC: Cypher Metaverse Inc. (Cypher, CODE, or the Company) seeks early-stage investments in emerging technology sectors, including the blockchain ecosystem, fintech and the metaverse. The Company identifies such opportunities and applies its relationships and capital to advance its interests.

2026-06-17 22:25

Director Alford Peggy 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009177

2026-06-17 22:21

Director Songhurst Charles 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009174

2026-06-17 22:21

Director Elkann John 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009173

2026-06-17 22:20

Director Andreessen Marc L 🟢 acquired 490 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009172

2026-06-17 22:19

Director Collison Patrick 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009171

2026-06-17 22:16

Director Houston Andrew 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009170

2026-06-17 22:15

Director Killefer Nancy 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009169

2026-06-17 22:15

Director Xu Tony 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009168

2026-06-17 22:14

Director KIMMITT ROBERT M 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009167

2026-06-17 22:13

Director Arnold John Douglas 🟢 acquired 612 shares (1 derivative) of Meta Platforms, Inc. (META) Transaction Date: Jun 15, 2026 | Filing ID: 009166